T 0128/19 (Phagocytosis/LELAND STANFORD JUNIOR UNIVERSITY) of 11.03.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T012819.20210311
- Date of decision
- 11 March 2021
- Case number
- T 0128/19
- Petition for review of
- -
- Application number
- 09701993.9
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Methods for manipulating phagocytosis mediated by CD47
- Applicant name
- The Board of Trustees of the Leland Stanford
Junior University - Opponent name
- O1: Tioma Therapeutics, Inc
O2: Blink Biomedical
O3: Bristol-Myers Squibb Company
O4: Avidity IP Limited
O5: Wilding, James Roger
O6: Surface Oncology, Inc.
O7: Strawman Limited - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2) (2007)
- Keywords
- Basis of decision - text or agreement to text withdrawn by patent proprietor
Basis of decision - patent revoked - Catchword
- -
- Cited cases
- T 0073/84
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.